ID: ALA2283322

Max Phase: Preclinical

Molecular Formula: C18H17N3O2

Molecular Weight: 307.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCCCC(=O)NN=C1c2ccccc2C(=O)c2ccccc21

Standard InChI:  InChI=1S/C18H17N3O2/c19-11-5-10-16(22)20-21-17-12-6-1-3-8-14(12)18(23)15-9-4-2-7-13(15)17/h1-4,6-9H,5,10-11,19H2,(H,20,22)

Standard InChI Key:  DRGWMKCELLGMNY-UHFFFAOYSA-N

Associated Targets(non-human)

Abat Gamma-amino-N-butyrate transaminase (95 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1321AlogP: 1.84#Rotatable Bonds: 4
Polar Surface Area: 84.55Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.72CX Basic pKa: 9.98CX LogP: 1.84CX LogD: -0.51
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: -0.52

References

1. Bansal SK, Sinha BN, Khosa RL.  (2013)  -Amino butyric acid analogs as novel potent GABA-AT inhibitors: molecular docking, synthesis, and biological evaluation,  22  (1): [10.1007/s00044-012-0023-0]

Source